Oakley, AM2022-05-092022-05-091996-05(1996). Australasian Journal of Dermatology, 37(2), 96-98.0004-8380https://hdl.handle.net/2292/59068Repigmentation occurred within a few weeks of discontinuing successful depigmentation therapy with monobenzyl ether of hydroquinone, in a patient with extensive vitiligo. Patients undertaking depigmentation therapy should be warned that this may occur. The mechanism is unknown.PrintItems in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htmHumansFacial DermatosesVitiligoRecurrenceHydroquinonesSkin PigmentationPUVA TherapyAdultMaleClinical Research1103 Clinical Sciences1114 Paediatrics and Reproductive MedicineJournal Article10.1111/j.1440-0960.1996.tb01014.x2022-04-19Copyright: The author8687336 (pubmed)http://purl.org/eprint/accessRights/RestrictedAccess1440-0960